Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update. - Wikidata - wikimedia - TriplyDB

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

http://www.wikidata.org/entity/Q37940301

about

Obesity Induces Artery-Specific Alterations: Evaluation of Vascular Function and Inflammatory and Smooth Muscle Phenotypic Markers.Endothelial NO and O₂·⁻ production rates differentially regulate oxidative, nitroxidative, and nitrosative stress in the microcirculation Denture-related stomatitis is associated with endothelial dysfunction.Investigating the potential role of TRPA1 in locomotion and cardiovascular control during hypertension.Low mercury concentration produces vasoconstriction, decreases nitric oxide bioavailability and increases oxidative stress in rat conductance artery.Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Giα-coupled β2-adrenoceptor signaling pathway Aerobic Exercise Training Prevents the Onset of Endothelial Dysfunction via Increased Nitric Oxide Bioavailability and Reduced Reactive Oxygen Species in an Experimental Model of Menopause.Long-term, regular remote ischemic preconditioning improves endothelial function in patients with coronary heart disease Eugenol dilates mesenteric arteries and reduces systemic BP by activating endothelial cell TRPV4 channels.Long-term improvement of arterial wall characteristics in patients with diabetes mellitus type 1 using cyclic, intermittent treatment with a low-dose fluvastatin and valsartan combination.Nitrative Stress Participates in Endothelial Progenitor Cell Injury in Hyperhomocysteinemia.Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions.Dihydrotestosterone modulates endothelial progenitor cell function via RhoA/ROCK pathway.Exercise training and cardiometabolic diseases: focus on the vascular system.Heart Rate Recovery and Risk of Cardiovascular Events and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies Coronary microvascular dysfunction in diabetes mellitus.Obesity, Inflammation, and Exercise Training: Relative Contribution of iNOS and eNOS in the Modulation of Vascular Function in the Mouse Aorta.The Impact of Remote Ischemic Preconditioning on Arterial Stiffness and Heart Rate Variability in Patients with Angina Pectoris.Effects of dihydrotestosterone on adhesion and proliferation via PI3-K/Akt signaling in endothelial progenitor cells.Hyperglycaemia in pregnant rats causes sex-related vascular dysfunction in adult offspring: role of cyclooxygenase-2.Effects of an Antimutagenic 1,4-Dihydropyridine AV-153 on Expression of Nitric Oxide Synthases and DNA Repair-related Enzymes and Genes in Kidneys of Rats with a Streptozotocin Model of Diabetes Mellitus.Endothelial Dysfunction and Inflammation Precedes Elevations in Blood Pressure Induced by a High-Fat Diet.

P2860

Q33561129-249B9A88-CE03-4A99-9129-4CA3B4F58D6E Q33732455-6317D7F2-857A-46DC-9985-6E4160B0F441 Q33876505-79410E6A-D46F-4282-8ED1-04FAF88DD6A9 Q34292579-B0CABEF9-9547-40EC-92E8-5029700AEBC3 Q34473866-42ADD632-D5DF-46F6-85AA-94921E7C5439 Q35119132-28F49129-9194-4B7D-AE5C-B55C91775EA6 Q35553520-2031D4EC-E115-46DB-BE2B-0A94518E6B6D Q35750878-3BAD0D5E-8E6F-4347-82DC-D2EE7A9FDD76 Q35865417-5134B317-0B5C-4367-A456-096043BA960B Q35942738-C7B9F23C-5758-4BBD-9683-BF5374D4CFE1 Q36071627-D74F2D6A-463C-4C09-999C-F5B511682E59 Q37328835-D720CB59-6732-4D83-B065-A1350CF418D8 Q37393444-DA38F93F-2800-4BA3-AA8D-3DC9C37B2E3C Q38092016-D0A72E06-3A43-4B35-A7EA-BC1724AB9631 Q39294300-EFD93A1A-0F38-4B3E-9FEF-F822FA342324 Q39393549-A12C2FCF-4059-45DC-8D50-D0287CD3D3C7 Q41026978-BDF5417C-3D80-4184-AFA9-8916D7C84DDA Q41981170-83862C41-CA4F-4F15-A9CC-59827566A435 Q43420530-B7BD9F9E-665F-4807-AE5F-0B494AEA426C Q47748722-65940BF7-36AE-4D5E-8AE2-332350EE75F7 Q53101315-F28FF583-ED1B-4F93-AD15-665D04DE8599 Q55431810-C46AC59B-1320-45E5-A303-C06ECD85F464

P2860

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

http://www.wikidata.org/entity/Q37940301

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

@en

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

@nl

type

label

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

@en

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

@nl

prefLabel

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

@en

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

@nl

P1433

Q37940301-BFC6A7F0-A08A-4CF2-A95F-04A63CF1C40A

P1476

Q37940301-2E581010-B972-4064-8E27-0957939F0855

P2093

Q37940301-302B9E99-F255-4231-B7E9-9070B3BD32FA

Q37940301-4F53E5AC-22B6-4DA6-A5E0-C6657BE739C1

Q37940301-B5BE5A5C-375F-4ED1-B6D3-2B537259992A

Q37940301-BC21FB2F-2C70-4632-9E6C-531396DF2317

Q37940301-E1BDC18A-A966-436F-BABE-5364B5DCF2BA

Q37940301-E3AF75FF-B664-466C-93C1-50F71667B6B2

Q37940301-E5C6D914-6486-4886-A838-898EEEB44501

P2860

Q37940301-0F3D4599-1103-4336-9B44-2CC42A9CD303

Q37940301-1072F22D-501D-4A6E-B352-49FE77B75D67

Q37940301-10CE35E0-B97F-4943-BAE2-5824BEF03CC9

Q37940301-1572BCCE-CEE9-48DF-936C-007081C67AE4

Q37940301-19DA40DC-EFA4-4C20-877A-FBC47C9528C6

Q37940301-22CC3561-ED2A-4525-A977-011BF6DA4FD5

Q37940301-287C0662-6DE8-4091-8044-06D3B30BE6FE

Q37940301-304A7643-6BA3-482D-9589-1C29D362C181

Q37940301-338812C1-212E-4C4A-8C2C-B3480E5F7065

Q37940301-3A923ACF-3D5B-4736-A321-A63C837B7909

P304

Q37940301-B844E35F-9C0A-43A0-9564-E1F0270CB831

P31

Q37940301-5E86FD57-2DB9-4468-85DD-D7BCF11BDE41

P356

Q37940301-42106154-7DD5-45C9-A081-4CB27673D1EE

P407

Q37940301-1F273C63-A086-4DD1-91B0-E9B4C4D0B63A

P433

Q37940301-5973A609-8D49-4D68-867B-5FCA0461F9FA

P478

Q37940301-831331B4-EC7A-4542-B9F8-C66D5D9CDAB8

P577

Q37940301-5702590C-3CC3-4B35-9440-C270CAD7137F

P5875

Q37940301-9EE2DF28-E40D-4A13-B28B-7216CD6BA19B

P698

Q37940301-3CF1977B-963E-48FF-A4DB-BD57D737A466

P921

Q37940301-1D5E5580-7FA1-4059-9AC3-E6EFF5BE3A44

Q37940301-DEF67CB0-AA6B-42F9-A58D-3F310A16C474

P356

S0100-879X2011007500104

P1433

Brazilian Journal of Medical and Biological Research

P1476

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.

@en

P2093

A P Davel

http://www.w3.org/2001/XMLSchema#string

C F Wenceslau

http://www.w3.org/2001/XMLSchema#string

E H Akamine

http://www.w3.org/2001/XMLSchema#string

F E Xavier

http://www.w3.org/2001/XMLSchema#string

G K Couto

http://www.w3.org/2001/XMLSchema#string

H T Oliveira

http://www.w3.org/2001/XMLSchema#string

L V Rossoni

http://www.w3.org/2001/XMLSchema#string

P2860

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease

Vascular endothelial cells synthesize nitric oxide from L-arginine

Increased superoxide anion production by interleukin-1beta impairs nitric oxide-mediated relaxation in resistance arteries

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Mortality by cause for eight regions of the world: Global Burden of Disease Study

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans.

Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta

P304

920-932

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0100-879X2011007500104

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51679168

http://www.w3.org/2001/XMLSchema#string

P698

21956535

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio